Snore Defense

Product NDC
50845-0251
Requested package NDC
50845-0251-1
11-digit product format
508450251
Labeler code
50845
Product ID
50845-0251_df521eee-ede6-4a79-96de-ce9b70d4be45
Type
HUMAN OTC DRUG
Nonproprietary name
Antimonium tartaricum, Carbo vegetabilis, Grindelia (Robusta), Lung suis, Mucosa nasalis suis, Nux vomica, Quebracho, Sticta pulmonaria, Teucrium marum
Dosage form
SPRAY
Route
ORAL
Labeler
Liddell Laboratories
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2019-04-02
Marketing end
2024-04-02
Substance
ANTIMONY POTASSIUM TARTRATE; ACTIVATED CHARCOAL; GRINDELIA HIRSUTULA FLOWERING TOP; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; STRYCHNOS NUX-VOMICA SEED; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; LOBARIA PULMONARIA; TEUCRIUM MARUM
Active strength
200 [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage50845-025150845-0251-1DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50845-0251-12021-12-21C16284748780-1ba0f9c33-4e3e-a910-e053-dadaa90a0b85Drug Facts:
50845-0251-12021-01-29C16284748780-1ba0f9c33-4e3e-a910-e053-dadaa90a0b85Drug Facts:

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50845-0251-15084502510130 mL in 1 BOTTLE, SPRAY (50845-0251-1) 30 ml2019-04-022024-04-02NoNoCurrent